Choi JW - Search Results

1

Transcriptome-based deep learning analysis identifies drug candidates targeting protein synthesis and autophagy for the treatment of muscle wasting disorder.

Lee MH, Lee B, Park SE, Yang GE, Cheon S, Lee DH, Kang S, Sun YJ, Kim Y, Jung DS, Kim W, Kang J, Kim YR, Choi JW. Lee MH, et al. Among authors: choi jw. Exp Mol Med. 2024 Apr;56(4):904-921. doi: 10.1038/s12276-024-01189-z. Epub 2024 Apr 1. Exp Mol Med. 2024. PMID: 38556548 Free PMC article.

2

In vivo imaging of Lgr5-positive cell populations using confocal laser endomicroscopy during early colon tumorigenesis.

Choi JW, Kim JK, Choi M, Kim YR, Yun SH. Choi JW, et al. Among authors: choi m. Endoscopy. 2014 Dec;46(12):1110-6. doi: 10.1055/s-0034-1377631. Epub 2014 Sep 12. Endoscopy. 2014. PMID: 25216325 Free PMC article.

3

Longitudinal Tracing of Spontaneous Regression and Anti-angiogenic Response of Individual Microadenomas during Colon Tumorigenesis.

Choi JW, Kim P, Kim JK, Kim YR, Fukumura D, Yun SH. Choi JW, et al. Theranostics. 2015 Apr 1;5(7):724-32. doi: 10.7150/thno.10734. eCollection 2015. Theranostics. 2015. PMID: 25897337 Free PMC article.

4

Transcriptome analysis indicates TFEB1 and YEATS4 as regulatory transcription factors for drug resistance of ovarian cancer.

Kim YR, Park MS, Eum KH, Kim J, Lee JW, Bae T, Lee DH, Choi JW. Kim YR, et al. Among authors: choi jw. Oncotarget. 2015 Oct 13;6(31):31030-8. doi: 10.18632/oncotarget.5208. Oncotarget. 2015. PMID: 26307679 Free PMC article.

5

Blood Droplet-Based Cancer Diagnosis via Proteolytic Activity Measurement in Cancer Progression.

Choi JW, Lee H, Lee G, Kim YR, Ahn MJ, Park HJ, Eom K, Kwon T. Choi JW, et al. Theranostics. 2017 Jul 8;7(11):2878-2887. doi: 10.7150/thno.19358. eCollection 2017. Theranostics. 2017. PMID: 28824722 Free PMC article.

6

Fluorescent cell-selective ablation using an adaptive photodynamic method.

Kim YR, Kim JK, Choi JW. Kim YR, et al. Among authors: choi jw. Chem Commun (Camb). 2017 Nov 16;53(92):12434-12437. doi: 10.1039/c7cc07550b. Chem Commun (Camb). 2017. PMID: 29099527

7

Evaluation of pemetrexed and etoposide as therapeutic regimens for human papillomavirus-positive oral and oropharyngeal cancer.

Kim YR, Lee B, Byun MR, Lee JK, Choi JW. Kim YR, et al. Among authors: choi jw. PLoS One. 2018 Jul 11;13(7):e0200509. doi: 10.1371/journal.pone.0200509. eCollection 2018. PLoS One. 2018. PMID: 29995943 Free PMC article.

8

Integrin α6 as an invasiveness marker for hepatitis B viral X-driven hepatocellular carcinoma.

Kim YR, Byun MR, Choi JW. Kim YR, et al. Among authors: choi jw. Cancer Biomark. 2018;23(1):135-144. doi: 10.3233/CBM-181498. Cancer Biomark. 2018. PMID: 30010110

9

Selective killing of circulating tumor cells prevents metastasis and extends survival.

Kim YR, Yoo JK, Jeong CW, Choi JW. Kim YR, et al. Among authors: choi jw. J Hematol Oncol. 2018 Sep 10;11(1):114. doi: 10.1186/s13045-018-0658-5. J Hematol Oncol. 2018. PMID: 30201021 Free PMC article.

10

Correction to: Selective killing of circulating tumor cells prevents metastasis and extends survival.

Kim YR, Yoo JK, Jeong CW, Choi JW. Kim YR, et al. Among authors: choi jw. J Hematol Oncol. 2019 Jan 9;12(1):5. doi: 10.1186/s13045-018-0688-z. J Hematol Oncol. 2019. PMID: 30626405 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,698 results

Search Page

Filters